CSTL · Castle Biosciences Inc
United States · RS rating 78 · As of 2026-10-14
| Price | 33.11 USD |
|---|---|
| 1-day change | +0.7% |
| RS rating (overall / 1M / 3M / 12M) | 78 / 31 / 94 / 88 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 26 / 43 / 11 |
| Industry group (rank) | Medical-Services (44) |
| EPS growth Q/Q | -512.5% |
| Sales growth Q/Q | +4.8% |
| Distance from 52-week high | +23.1% |
| Market cap (USD) | $717.7M |